Analyst Expectations for Crinetics Pharmaceuticals's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on Crinetics Pharmaceuticals (NASDAQ:CRNX) stock. The analysts have an average price target of $38.2 versus the current price of Crinetics Pharmaceuticals at $16.62, implying upside. This average price target has increased by 9.14% over the past month.
August 09, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts predict an upside for Crinetics Pharmaceuticals with an average price target of $38.2, a significant increase from the current price of $16.62.
The average price target given by analysts suggests a significant upside for Crinetics Pharmaceuticals. This indicates a positive outlook for the company's stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100